Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of ($0.59), $0.11 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $51.6 million versus the consensus estimate of $49.32 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.